Regulatory & Reimbursement
Market Pathways Scorecard: FDA Trends Edition
A graphic look at Q1 2024 approvals and review status.
Welcome to MyStrategist, the digital home for Market Pathways.
Market Pathways covers the people, challenges, and opportunities impacting the global medtech regulatory, reimbursement, and policy communities. We invite you to explore our coverage. Think Strategically.
Subscribe Today
Start a free trial and unlock 5-days of exclusive subscriber-only access to MedTech Strategist & Market Pathways
Start Trial
First Takes
CMS Pushes Back on New-Tech Applications, But Activity Remains Strong
The Medicare agency is on a path to potentially approve more new technology add-on payments for devices entering the hospital inpatient setting next year than it has since the NTAP program launched, even after disqualifying eight products under new eligibility requirements.
Don't Just Advertise... Strategize!
Advertise with MedTech Strategist and be seen by medtech's most influential executives.
Learn More
Regulatory & Reimbursement
Pathways Document Depot: Cataloging Medtech Policy
A sortable and searchable running inventory of global medtech regulatory and policy official documents, including rules, guidance documents, memos, white papers, and more from national authorities, non-governmental groups, and global organizations.